Palantir, a software company that builds big data platforms, was co-founded by billionaire investor Peter Thiel and former PayPal employees in 2004, according to Bloomberg. Under the new contract, Palantir will provide software for the National Center for Advancing Translational Sciences and its related agencies.
Scientists at the associated NIH centers will be able to use Palantir’s software to combine proprietary and public research data into one interface, including screening, genomics and other biological data.
“NCATS’ mission is to get more treatments to patients more quickly,” Andrew Girvin, PhD, head of biomedical research and development at Palantir, said in a news release. “By bringing together disparate data into one interface, researchers will soon benefit from greater insights in a fraction of the time.”
More articles on data analytics and precision medicine:
Meharry Medical College launches data science institute to improve care in minority populations
Ascension, Banner Health among 6 newest hospitals to join Syapse’s precision oncology network
New app from Tempus brings clinical, genomic data to physicians at point of care
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
